| Serial Number | 97382032 |
| Word Mark | NANOPORTAL |
| Filing Date | Tuesday, April 26, 2022 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, February 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, obesity or non-alcoholic metabolic dysfunction associated steatohepatits, and psychological diseases being Alzheimer's, dementia, parkinson's, sociopathy or psychopathy. depression, bipolar disorder, addiction, schizophrenia, alzheimer's disease, immune system diseases being Arthritis (osteoarthritis and rheumatoid arthritis), Lupus and other organ diseases being hypertension, dyslipidemia, Obstructive Sleep Apnea, and chronic pain. |
| Goods and Services | Nanoporous membranes in inorganic chemical form used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes in inorganic chemical form used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant; nanoporous membranes in inorganic chemical form used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases, namely, metabolic diseases being diabetes, obesity or non-alcoholic metabolic dysfunction associated steatohepatits, and psychological diseases being Alzheimer's, dementia, parkinson's, sociopathy or psychopathy; nanoporous membranes in inorganic chemical form used for improving medication adherence in the treatment of chronic diseases namely, metabolic diseases being diabetes, obesity or non-alcoholic metabolic dysfunction associated steatohepatits, and psychological diseases being Alzheimer's, dementia, parkinson's, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases being diabetes, obesity or non-alcoholic metabolic dysfunction associated steatohepatits, and psychological diseases being Alzheimer's, dementia, parkinson's, sociopathy or psychopathy, depression, bipolar disorder, addiction, immune system diseases being Arthritis (osteoarthritis and rheumatoid arthritis), Lupus and other organ diseases being hypertension, dyslipidemia, Obstructive Sleep Apnea, and chronic pain. |
| Goods and Services | Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; miniature long-term drug implants utilizing proprietary implantable drug delivery technology. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, May 13, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, May 13, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 2, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Vivani Medical, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Alameda, CA 94502 |
| Event Date | Event Description |
| Friday, April 29, 2022 | NEW APPLICATION ENTERED |
| Monday, May 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 13, 2023 | ASSIGNED TO EXAMINER |
| Friday, May 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 15, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 15, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 15, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, May 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 30, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, November 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 30, 2023 | SUSPENSION LETTER WRITTEN |
| Tuesday, May 30, 2023 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, May 30, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, December 14, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, November 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 5, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, November 27, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, December 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 19, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, February 24, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 24, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 24, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 19, 2024 | NON-FINAL ACTION WRITTEN |